INSUBCONTINENT EXCLUSIVE:
Sun Pharma racked up its biggest rally in four months, soaring over 8 per cent, after the US Food and Drug Administration (USFDA) updated
conditions were found at the plant, the issues do not justify further regulatory action and any corrective action is left to the FDA to take
The BSE Sensex was down 75 points, or 0.21 per cent, at 35,387.
The USFDA had made three observations in February after inspecting the
factory in Gujarat for failing to meet good manufacturing practice (GMP) standards.
With the rally, the stock moved above its 50-, 100- and
